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Connexin-43 and Traumatic
Brain Injury
A potential target for therapeutic intervention
by Lauren R. Moore
Eastern Kentucky University

ABSTRACT
Traumatic Brain Injury (TBI) is a widespread, degenerative affliction
with no current therapeutic interventions. The long-term degradation
caused by TBI results from secondary injury cascades that are initiated by
primary injury. An early and important step in the damage process is
reactive astrogliosis in astrocytes. Astrocytes communicate through gap
junctions, which are composed of two connexon hemichannels from the
two communicating cells and these connexons themselves are composed
of six connexin protein subunits. Connexin 43 (Cx43) is a particularly
important connexin to gap junctional communication and could act either
to preserve the astrocytes from oxidative stress, or to propagate the
damage signals to otherwise healthy cells. The present study investigates
the expression of Cx43 in different treatment types in hippocampal
samples of Wistar rats in order to elucidate the relationship between
Cx43 and secondary injury through Real-Time PCR (qPCR) and cell culture
work. While Cx43 has a trend for increased expression in traumatized
tissue that is returned to normal levels with an antioxidant treatment,
these results are not statistically significant according to a single- sided
ANOVA test. Further research is needed to understand the relationship
between Cx43 and secondary injury.
INTRODUCTION
The major health issues responsible for injury and death in the
United States are typically accompanied by a slew of possible medications
and therapies available to the patient. However, traumatic brain injury
(TBI), one of the most significant sources of injury and long-term
complications occurs in many ways and impacts people in all walks of
life. Whether from car accidents, military injuries, recreational accidents,
occupational hazards, professional football or high school basketball, TBI
is a prominent and pervasive detriment to health and well-being. There
are approximately one to two million new incidences of moderate TBI
(mTBI) that are documented in the US annually, not including unreported
cases (Lovell et al., 2004). Moreover, TBI is a severe affliction throughout
the globe with an estimated incidence of 200 per 100,000 people
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annually, although this is most likely a significant underestimate given
the limitations of a global census (Bryan-Hancock and Harrison, 2011).
Moreover, the popularity of high school sports makes mTBI a serious
threat to young people through multiple concussions during athletic
competition, making young people vulnerable to life-long degenerative
afflictions as there is no established pharmaceutical intervention or
effective therapy to allay disease progression.
TBI is an overarching term describing both the macroscopic and
microscopic physiological processes that occur in response to brain
trauma. The initial primary injury is classified in multiple ways based on
the size of the affected area, whether or not the skull was penetrated,
and the severity of the injury. There are several scales employed to
classify the severity of the injury. One diagnostic tool for categorization
of injury is the Glasgow Coma Scale, which assesses different responses
and functions of the injured patient and translates the results of these
various criteria into a numerical score, corresponding to one of three
possible ranges representing mild, moderate, and severe TBI (Orange
County Neurology Medical Center, n.d.) Severe head injury typically has a
Glasgow Coma Scale score less than eight, moderate head injury between
nine to twelve and mild injury between thirteen and fifteen (Miller, 2013).
Concussions are typically associated with mild TBI. Other classifications
of TBI are based on whether or not the damaged tissue is exposed to the
local environment and also applied. Focal injuries affect one particular
area, whereas diffuse injuries cause more widespread damage. Open TBI
refers to injuries in which the skull is penetrated and the wound is
exposed, whereas closed TBI involves damage to the brain where the
skull remains intact and the brain tissues remain unexposed and
separated from the local environment (Heegaard, et al., 2013).
Primary injury, which occurs at the time the trauma is incurred, is
considered irreversible; however, the secondary injuries that result from
the cytotoxic cascades and destructive biochemical events that occur
within cells could potentially be interrupted, possibly limiting the damage
typically associated with moderate TBI. The biochemical and cellular
events that occur following primary TBI and eventually lead to the
damages associated with secondary TBI are complex and heavily
researched. Certain events are known to occur following TBI starting with
massive, widespread neuronal depolarization and eventually leading to
lipid peroxidation, increase in glial-fibrillary acidic protein (GFAP),
reactive gliosis, release of excitatory amino acids such as glutamate,
higher calcium influx into neurons leading to increased generation of
excitatory postsynaptic potentials (EPSPs), nitric oxide (NO) release, and
cytotoxicity (Greve, M.W. and B. Zink, 2009). These physiological and
biochemical changes initiate the accumulation of damage seen in
secondary injury, causing damage to neurons and glial cells and
impairing neuronal communication and synaptic transmission, thereby
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facilitating a decrease in brain function including impaired learning and
memory formation. Three key facets of secondary injury are increased
levels of glutamate, free radicals and NO, which constitute a mutuallyamplifying triad, referred to as the tripartite synthesis, perpetuating and
propagating neuronal damage (Greve, M.W. and B. Zink, 2009). A less
emphasized result of TBI is the transient increase in gap junctional
coupling that occurs following trauma (Franseva et al., 2002).
Gap junctions are critical facilitators of intercellular signaling
formed by the interaction of two different cells’ connexons, which are
hemichannel proteins embedded in the cells’ plasma membranes. These
connexon hemichannels are each composed of six smaller connexin (Cx)
protein subunits. Connexin proteins have a short half-life of
approximately one to three hours, demonstrated from in vitro tissue
cultures (Solan and Lampe, 2007). This rapid recycling indicates that
connexin expression is a tightly regulated and adaptable process capable
of undergoing rapid alterations in response to cellular changes. Connexin
proteins are synthesized in the rough endoplasmic reticulum (RER),
passed through the trans-Golgi complex, and finally trafficked via vesicles
to the plasma membrane. Oligomerization of the six connexin subunits
into one connexon hemichannel is believed to begin in the ER as the
protein is synthesized, and end in the Golgi apparatus, where further
modifications are completed (Lampe and Lau, 2004).
During this process, the identity of the connexon is established
through its connexin composition. Twenty different connexin isoforms
are known to exist in the human genome, classified by their molecular
weight and their genetic relatedness. Dysfunction and dysregulation of
connexins has been implicated in a variety of diseases including… (Wei et
al., 2014). Any of these connexins can be recruited during
oligomerization to form connexons, giving rise to profound potential for
diversity among connexons.
Obstruction of the glial network, and consequential neuronal
signaling dysfunction, is considered to be a major contributor in the
accumulation of long-term damage from mTBI (Prochnow et. al, 2014). It
is likely that gap junctional communication allows for the transmission of
damage signals produced through the secondary injury of TBI or,
alternatively, allows for the rapid distribution of these signals throughout
the glial network to prevent individual afflicted cells from harboring lethal
levels of these damaging agents. Either way, changes in gap junctional
communication are likely to play an important role in secondary injury
from mTBI.
Due to the vast array of possible connexon conformations, there
are connexon classifications based on composition. Connexons
consisting of six identical connexin subunits are called homomeric
hemichannels, whereas connexons consisting of different connexin
subunits are called heteromeric hemichannels. Different connexin
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isoforms have varying abundances in various cell types, suggesting
functional relevance in their respective cell type (Wei et al., 2004). Further
contributing to the diverse repertoire of gap junctional communication is
the composition of the gap junctions themselves. While gap junctions are
composed of two different connexon hemichannels, they do not have to
be composed of identical connexons. A gap junction is homotypic if the
connexon hemichannels contributed by both interacting cells are
identical, and heterotypic if they are not. The possibility for diversity at
multiple levels in gap junction formation allows for an abundant resource
for gap junction communication, and different biological functions
among differently structured gap junctions. Permeability, weight,
selectivity for ions and electrical conductance are all factors that diverge
widely in channels formed by different connexin subunits (Nagy and
Rash, 2000).
Connexin-43 (Cx43) is the most widely-expressed connexin in the
body, having important roles in development and important roles in
specific tissues and cell types because, unlike many other connexin
isoforms, it not only is expressed throughout development, but also
continues to be expressed into adulthood (Dbouk, et al., 2009; Chang
and Balice-Gordon, 2000). Cx43 is particularly known for its importance
in astrocytes, one of the four glial cell types found in the brain.
Astrocytes play a critical role in maintaining homeostasis to support
healthy neuronal function by encasing regions of axons and whole
synapses and acting as insulation and protection from the surrounding
fluctuating ionic environment, allowing for different ionic conditions to
exist in close proximity and also help maintain stable levels of
extracellular potassium ions.
The vast coupling of astrocytes in the brain forms a glial syncytia,
or network, allowing for uniformity of cytoplasmic composition, rapid
signaling, and widespread distribution of ions and metabolites. Astrocytic
elements with gap junctions tend to localize near neuronal structures,
surrounding synapses, along the unmyelinated Nodes of Ranvier of
axons, and near glomeruli; these gap junctions universally contain Cx43,
although the Cx43 concentration in astrocytic gap junctions is not
uniform and is more localized at points of close interaction between
astrocytes and neuronal structures (Nagy and Rash, 2000). Most
connexins are expressed in glial cells, implicating connexins as important
players in proper maintenance and functioning of the glial network.
Astrocytes are also important from their role in influencing the blood
brain barrier (BBB) through the interactions between their end-feet
projections and the capillaries of the BBB. Astrocytes respond to TBI by
becoming reactive and undergoing astrogliosis, which ultimately leads to
formation of a glial scar. Typically, astrocytic projections do not overlap
with one another; however, reactive astrocytes increase their synthesis of
glial fibrillary acidic protein (GFAP) – commonly used to stain astrocytes
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in vitro – and vimentin, two intermediate filaments that help develop the
cytoskeletal scaffolding needed for the projections to grow and extend
outward, overlapping with neighboring astrocytes. The consequential
glial scar formed provides a physical barrier to prevent further interaction
between injured and healthy neurons, and a chemical barrier due to its
growth-inhibiting secretions. This has both detrimental and beneficial
effects. Formation of the glial scar is needed to help maintain and repair
the integrity of the BBB; however, it prevents neurons from growing and
regenerating properly. Axon projections attempt to extend only to be
blocked by the network of overlapping astrocytes that form a
homogenous barricade via their gap junctional connections. Cx43’s
interactions with cytoskeletal proteins and subunits affect the scaffolding
and shape of the cell, as changes in cell shape have been observed
following mTBI. In regard to cell arrangement, a monolayer of cells has
been demonstrated to be more effective for neuroprotection and better
for cell survival.
Currently, there is no effective therapeutic intervention available to
allay the secondary injury associated with TBI. Current research seeks to
understand the events involved in propagating this damage in hopes of
finding a point in the cytotoxic cascade to target and interrupt the
accumulation of damage. Many important facets of secondary injury have
been described, but scarce research has been conducted on the role of
gap junctional coupling in transmitting these damaging signals, given its
apparent importance. There is a need for understanding the role of
connexin components in the gap junctional communication associated
with TBI; particularly, connexin-specific regulators need to be identified
and connexin-specific contributions to TBI must be established.
Additionally, the relative abundance of the different connexin isoforms in
different regions of the brain must be quantified definitively and mapped
out and relative biological function of each connexin isoform established,
including the nature and consequences of Cx43’s interactions with
myriad proteins.
Among the research conducted on this topic, various studies have
reported a damaging effect of Cx43-gap junctions through its spread of
damage signals to otherwise healthy neighboring cells in the glial
syncytium (Frantseva et al., 2002). Moreover, Cx43 deletion in astrocytes
of mouse brain resulted in milder injury and less ATP release from
damaged cells, a significant factor in secondary injury accumulation,
indicating that Cx43 presence begets cellular damage. Tissues bordering
spinal cord injury (SCI) sites demonstrated upregulated Cx43 (Huang,
2012). Notably, Cx43-knockout mice exhibited less severe reactive
astrogliosis following TBI and failed to develop Cx43 plaques like their
wild-type counterparts. This study concluded that gap junctions
destructively spread damage signals following trauma (Huang et. al,
2012). Cx43-gap junctional channels are exceptionally permeable to ATP,
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ADP, and AMP (Lampe & Lau, 2004), making them potential regulators of
changes in cellular metabolism following injury.
Other studies have reported contrasting results supporting the
neuroprotective roles of such channels. One study concluded that
reactive astrogliosis was a neuroprotective process from their findings
that ablation of reactive astrocytes following controlled cortical impact
(CCI) trauma exacerbated injury, suggesting that its net effect was
protective in mTBI through limiting inflammation and preventing damage
to neural tissue. Interestingly, there was no net effect observed following
severe trauma, indicating that there is a threshold for the usefulness of
this possibly neuroprotective process (Myer et al., 2006).
Regardless of their contradictory findings, these studies tend to
agree that gap junctional coupling has an elusive, yet seemingly critical
role in attenuating or exacerbating neuronal apoptosis following mTBI
due to an apparent, transient increase in gap junctional coupling
following TBI (Frantseva et al., 2002). The notable correlation between
changes in the phosphorylation of Cx43 and changes in gap junctional
communication suggest that Cx43 has particular importance in the postTBI gap junctional communication processes, and also makes sense due
to its high permeability for ATP, ADP, and AMP. Phosphorylation mediates
Cx43 after trauma, and Cx43 throughout normal brain tissue is
overwhelmingly phosphorylated. Dephosphorylated Cx43 causes changes
in gap junctional intercellular communication (GJIC) and reported changes
in the conduction of the gap junction channel that may all be caused by
increased neural activity. Given that over 90% of homologous astrocytic
gap junctions contain Cx43 on both faces of the connection (Nagy &
Rash, 2000), it is possible that homotypic Cx43-composed gap junctions
are responsible for the patterns observed in gap junctional
communication post-TBI, as an increase in levels of Cx43 is observed,
accompanied by a structural modification that changes exposed epitopes.
However, this change is not observed in cases of severe trauma and
extensive neuronal damage; paradoxically, the Cx43 levels are actually
decreased in these regions of severe damage. There is a need for
understanding the relative levels of Cx43 and phosphorylated-Cx43
expressed in normal tissue and traumatized tissue, identifying specific
channel blockers, and identifying the nature of the damage signals
spread throughout the glial syncytium - IP3 a suggested candidate due to
its alleged involvement in cell death as well as the increase in IP3mediated signaling post-TBI (Frantseva et al., 2002).
Cx43 has the secondary classification of gap junction alpha-1 (Gja1), also the name of the gene that encodes the Cx43 protein. Gja-1 refers
to the similarities of Cx43 with other Cx protein sequences, and also
indicates that Cx43 was the first alpha Cx discovered, explaining why it
has the number one. Cx43 is known to have a short half- life, allowing for
its expression to be tightly regulated and rapidly altered (Dbouk, et al.,
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2009 and Lampe and Lau, 2004). Cx43 is a potential key player in
secondary injury post- TBI, although its role is evidently unclear and
highly debated due to its contradictory neuroprotective and also
neurotoxic effects. Knockout mice have been used in multiple studies to
assess the relationship between Cx43 and the extent of neuronal cell
death.
GFAP-positive astrocytes were found to be more abundant in
Cx43+/+ mice than Cx43+/- mice (Ohsumi, A. et al, 2000). These
findings indicate that a deficit in Cx43 expression could possibly disrupt
the accumulation of GFAP and somehow dampen reactive gliosis.
Furthermore, the extent of neuronal cell damage was significantly
reduced in Cx43 knockout mice (Franseva et al., 2002). The present study
hypothesizes that the presence of Cx43 in secondary injury processes
occurs early on in reactive astrocytes and is a precursor for the changes
observed in cellular metabolites and interactions seen later in secondary
injury. Since Cx43 directly associates with intermediate filament proteins,
and has been shown to undergo phosphorylation changes post-TBI that
ultimately have some effect on gap junctional communication (GJC) in the
glial syncytium, it is likely that the structural changes and consequential
functional changes that occur and rearrange Cx43’s exposed epitopes
allow for the upregulation of GFAP and vimentin proteins and
consequentially usher in astrogliosis. Due to the relationship between the
phosphorylation of Cx43 and its structural changes, as well as Cx43’s
interaction with intermediate filament proteins involved in astrogliosis, it
is possible that changes in Cx43 phosphorylation states lead to the
structural changes that occur in intermediate filaments of reactive
astrocytes. Given the Catch-22 effects of glial scar formation and reactive
astrocytes, it makes sense that changes in Cx43 would produce
contradictory neuroprotective and neurotoxic effects experimentally.
The relative levels of Cx43 phosphorylation have been shown to
have significant correlation with injury processes. Phosphorylation of
Cx43 is conferred by the extracellular-signal regulated kinase (ERK)
pathway, and this causes a significant reduction in the permeability of
these gap junctions (Ohsumi, A, et al., 2010; Prochnow, N., 2011). Given
that a relationship exists between the phosphorylated state of Cx43 (pCx43), the permeability of certain gap junctions, and post-injury
processes, it seems that Cx43 is a key player in secondary injury.
Moreover, experimentally induced expression of Cx43 provides
neuroprotection, but apparently not through gap junctional
communication, as this affect is still observed in the presence of gap
junctional blockers (Butkevich, et al., 2004). Levels of p-Cx43 are in flux,
with varying levels observable at different times post-injury and an
apparent peak of p-Cx43 levels at approximately six hours post-injury
(Ohsumi, et al., 2010). Astrocytes of the hippocampus demonstrated an
increase in p-Cx43 following mTBI, which induced ERK-regulated
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phosphorylation and led to an increase in Cx43 expression in these cells
apparently facilitating GJC among astrocytes of the hippocampus (Ohsumi
et al., 2004). Because the hippocampus is the region of the brain
primarily responsible for formation and storage of memories, damage to
the hippocampus results in learning and memory deficits. It seems that
Cx43 expression following mTBI is highly conditional upon the cellular
and environmental factors the cell is experiencing, demonstrating a
dependency on time, location and the state of neighboring cell types. It
may be that hemichannels composed of Cx43, as well as the gap
junctional coupling that occurs among them, have both damaging and
neuroprotective effects post-injury that dominate at different times and in
different circumstances.
The debate over whether reactive astrocytes are damaging or
neuroprotective is an argument between the “Good Samaritan” and the
“Bystander Effect” hypotheses. There is neuronal cell loss observed after
TBI, and also glial cell loss, including astrocytes; however, viable glial
cells respond to this damage by overcompensating, leading to reactive
gliosis. Cx43 is the connexin isoform most strongly associated with
astrocytes and, in traumatized astrocytes, may allow for propagation of
the harmful biochemical and messengers that lead to further secondary
tissue damage in what is commonly referred to as the ‘Bystander Effect,’
‘kiss-of-death,’ or cellular ‘fratricide.’ Cx43-composed gap junctions of
astrocytes cause an observable increase in calcium overload, oxidative
stress, and metabolic dysfunction (Ohsumi et al., 2004). Alternative to
this destructive, damage- signal-propagation effect is the idea of the
‘Good Samaritan,’ a neuroprotective strategy possibly employed by the
glial network in the spirit of ‘share-the-load,’ to prevent individually
damaged cells from reaching a critical load of harmful cytotoxins by
distributing these agents among otherwise healthy neighboring cells to
prevent any one cell from becoming overwhelmed. The neuroprotective
effect is supported by the contrasting observation of astrocytic Cx43-gap
junctions as scavengers of damaging cytotoxic agents (Ohsumi et al.,
2004). It is possible that the reactive astrocytes are both Good Samaritans
and Bystander Killers at different points in the secondary injury process.
The present study investigates the role of Cx43 in the secondary
incidence of mTBI to reveal a potential correlation between Cx43
expression and the biochemical events responsible for the secondary
injury associated with mTBI in order to shed light on the role of this
specific protein subunit and its importance as a therapeutic target.
Supported by the work of Franseva, et al., which calls for connexinspecific assessment of impact on neuronal cell death possible through
the use of specific anti- connexin antibodies, the present study assesses
the extent of fluctuation in Cx43 expression in response to different
treatments in astrocyte cell culture. Moreover, Frantseva, et al. maintain
that the levels of Cx43 synthesized and expressed in normal subjects is
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unestablished, identifying a need for this knowledge. The present study
seeks to somewhat address this gap in knowledge via comparative
analysis of Cx43 expression in normal hippocampal tissue samples from
a Wistar rat (sham), Wistar rats subjected to moderate TBI and treated
with saline (control), and Wistar rats subjected to moderate TBI and
treated with gamma-glutamylcysteine ethyl ester (GCEE), an antioxidant.
GCEE is an important antioxidant due to its ability to increase production
of glutathione (GSH), which is the most prominent antioxidant in the body
and helps to combat oxidative stress and reduce reactive oxygen species
(ROS) that are largely responsible for oxidative stress. The structure of
GCEE is depicted in Figure 16 and the structure of GSH is depicted in
Figure 18. Comparative analysis will be conducted through quantification
of Cx43 expression in the hippocampus through RNA extraction, reverse
transcription, and subsequent qPCR analysis of twenty different
hippocampal rat brain samples from three different experimental
populations: sham, TBI + saline, and TBI + GCEE.
MATERIALS & METHODS
Expression levels for Cx43 in different regions of the hippocampus
are quantified in the present through methods of RNA extraction, reverse
transcription, and real-time PCR (qPCR), and treatments on cultured
astrocytes alongside immunohistochemistry. RNA kit, and primers for
qPCR were all purchased from Life Technologies (Carlsbad, CA).
RNA Extraction Protocol:
• 100mg per sample were individually weighed from brain tissue
samples stored in the -80ºC and transferred on ice to separate
1.5mL tubes containing approximately 1mL each of RNAlater
reagent (Life technologies, Carlsbad, CA) and stored for
approximately 30 minutes.
• Brain tissue was removed from 1.5mL tubes and transferred to
individual Lysing Matrix D tubes containing 1mL each of Trizol.
• The tissue was lysed in a FastPrep-24 machine (NP Biomedicals,
Newport, CA) for six cycles at 45 seconds per cycle. In order to
prevent degradation of the tissue from excessive heating,
samples were iced for one minute between each cycle.
• The sample mixture was then pipetted from the Lysing matrix D
tubes, without transferring any beads from the Lysing Matrix D
tubes, to new 1.5mL tubes, which were subsequently shaken in
an incubator at room temperature for approximately five
minutes.
• Tubes were centrifuged at 12,000 x g at 4ºC for ten minutes to
separate the layers
• Liquid-liquid extraction was performed, pipetting the upper
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•

•

•

•
•
•

aqueous layer, without any material from the lower layer, into a
new 1.5mL tube for each sample.
Approximately 200µL of chloroform was added and
subsequently shaken for fifteen seconds by hand, then
incubated for 2-3 minutes at room temperature.
Tubes were centrifuged again at 12,000 x g at 4ºC for fifteen
minutes, and the upper aqueous layer was transferred into a
new tube, avoiding the transfer of any material from the lower
layers.
Approximately 300µL of cold isopropanol (stored at
approximately -20ºC for at least twenty minutes) was then
added to each tube and inverted five times by hand and
subsequently stored for thirty minutes at -20ºC.
Tubes were again centrifuged at 12,000 x g at 4ºC for
approximately ten minutes, and supernatant was pipetted off
and discarded, leaving pellets which were subsequently washed
with approximately 1mL of cold 75% ethanol (mixed one mL
nuclease-free water for every three mL absolute ethanol).
Small, white pellets were then vortexed back into solution and
subsequently centrifuged at 7,500 x g at 4ºC for ten minutes.
Ethanol was pipetted off and discarded and the pellet was
subsequently air dried at room temperature for five minutes,
although pellets were monitored to avoid complete desiccation.
Pellet was then resuspended in 100µL of nuclease-free water
and stored in the - 80ºC freezer for future use

NanoDrop Protocol:
• RNA samples were retrieved from the -80ºC freezer and thawed
on ice to prevent degradation of RNA.
• Once thawed, RNA samples were analyzed using a NanoDrop
spectrophotometer (Thermo Scientific, Waltham, MA). The
NanoDrop’s sensor was first cleaned by running a blank sample
of nuclease-free water.
• Each sample was briefly vortexed before a drop was pipetted
onto the NanoDrop’s sensor, and analysis was run using the
NanoDrop’s software technology; the Nanodrop sensor was
cleaned by wiping with a KimWipe between each sample run.
• NanoDrop analyses of all RNA samples’ concentration was
compiled (ng/µL) and purity was assessed (260/280 abs). A
spreadsheet of these results was produced and checked to make
sure samples were pure by looking at the 260/280 abs. A
260/280 sample readout with a ratio of two or less indicates a
purer sample.
• RNA samples were returned to the -80ºC freezer after use and
stored for later analysis.
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Gel Protocol:
• FlashGel™ System (Lonza Rockland, Inc., Rockland ME) for RNA
separation and analysis was used to verify the presence of RNA
and not DNA, since the NanoDrop cannot make this distinction.
The Flashgel™ System detects RNA quantities <10ng per band.
• RNA samples were removed from the -80ºC freezer and thawed
on ice to prevent degradation from heat.
• Once thawed, each RNA sample was prepared in a separate tube
with FlashGel™ Loading Dye (Lonza Rockland, Inc., Rockland ME
04841) so that each tube contained a 5µL load with a
concentration of less than or equal to 200ng of RNA per band;
for these wells, 2µL RNA were mixed by pipetting with 3µL
Loading Dye. These prepared loads were stored on ice until
ready for gel loading.
• Flashgel™ RNA Cassette was opened and flooded with nucleasefree water using a pipette. Water was subsequently absorbed
with a KimWipe by tilting the cassette and allowing the water to
drain out of the corner. Wells were not directly blotted or
handled.
• Flashgel™ RNA Cassette was loaded onto dock as shown in
Figure 5. Dock was subsequently connected to power supply
with red and black cables.
• Once connected, power supply was turned on and voltage was
set to 225mV. Top was snapped on to dock as shown in Figure
6, and gel was run for at least eight minutes without
interruption.
• After eight minutes, voltage was turned off and leads were
disconnected from power supply to remove cassette.
• Gel was then allowed to sit for approximately ten minutes and
subsequently exposed and photographed, as shown in Figure 7.
• RNA was returned to the -80ºC freezer for storage until further
use.
Reverse Transcription Reaction Protocol:
• RNA was removed from the -80ºC freezer and thawed on ice to
prevent degradation.
• Reverse Transcription is used to convert the RNA samples into
cDNA and was performed using a high-capacity cDNA kit
(Applied Biosystems, Foster City, CA, Part No. 4368814); cDNA
kit components were thawed on ice until ready for use.
• 2X RT Master Mix was prepared on ice, first by calculating the
volume of each kit component needed for the required number
of reactions, plus 10% of that number to account for any errors
or spills during transfer. Calculations were done for 31 samples,
so component volumes needed were calculated for 34.1 samples
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in order to provide enough excess in case of error, based on
initial sample size. Calculations were based by multiplying the
sample number by the volumes listed in Table 1.
The 2X Master Mix was mixed in a 1.5mL tube on ice then
mixed gently via pipette
10µL 2X master mix was then pipetted into 31 individually,
labeled 0.2mL PCR tubes for each reaction
10µL RNA sample was subsequently pipetted into corresponding
tube and pipetted up and down two times gently to mix. Tubes
were then sealed.
2mL tubes with their caps cut off were used as nests for
centrifugation. The 0.2mL reaction tubes were place in the 2mL
nested tubes centrifuge and centrifuged for approximately 15
seconds on pulse in order to eliminate any possible air bubbles.
Tubes were placed on ice until ready for loading into the
thermal cycler
Thermal cycler was programmed according to Table 4, which is
also depicted in Figure 8.

PCR Protocol:
• Real-Time PCR (qPCR) analyzes relative mRNA concentrations of
target genes expressed in samples, reflecting expression levels
of target genes. To run the reaction, Universal Master Mix
(Applied Biosystems, Carlsbad, CA) is used, which includes
Taqman primers and probes, as well as PCR reagents. The cDNA
made by reverse transcription of extracted mRNA is used to run
the reaction.
• Subsequently, reaction is run with both experimental assay gap
junction alpha-1 (Gja1, 87 amplicon length, Life Technologies,
Carlsbad, CA) as well as a control, glyceraldehyde-3-phosphate
dehydrogenase (Gapdh, 174 amplicon length, Life Technologies,
Carlsbad, CA), which should be equally expressed across all
cells since it is a “housekeeping gene” responsible for standard
cellular metabolism events. Half of the prepared reaction plate is
experimental and half the prepared reaction plate is control,
with each sample run twice (once on each side of the reaction
plate)
• 1µL of 20X TaqMan gene expression assay solution, 10µL 2X
gene expression master mix, and 8µL nuclease-free water were
used per reaction well. Before beginning, the amount of each
reagent needed was calculated based on the desired number of
reactions and these volumes were subsequently mixed in two
different reaction tubes, using Gapdh as the assay reagent for
one of the tubes, and Gja1 for the other.
• Gja1 assay solution was used as the experimental assay, and
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glyceraldehyde-3- phosphate dehydrogenase was used as a
control.
Assays were mixed by pipetting up and down twice and then
vortexed briefly.
1µL cDNA sample was subsequently added to each designated
well and a standard TaqMan PCR program was immediately
performed.
The ∆∆CT is run with desired number of well plates, “TaqMan
reagents” and “standard” (2 hour) time.
Plate layout must be assigned with “Plate set-up,” then “define
targets and samples.” Samples are defined by highlighting wells
and assigning them with either Gapdh control or with Gja1
experimental.
The plate is lined up to reflect the plate layout already assigned,
and then the run is started. The PCR reaction takes
approximately two hours per reaction plate.

Astrocyte Cell Culture Protocol:
Astrocytes were stored in liquid nitrogen tank until ready for use to
preserve viability (Invitrogen, Carlsbad, CA). Astrocytes were thawed in a
37º water bath for two minutes, swirling vial occasionally to ensure
complete melting of ice. All live cell culture work was done under a flow
hood to prevent contamination. UV-light in hood was turned on prior to
beginning and allowed to warm-up. Astrocytic media was prepared (85%
DMEM + 15% FBS) by removing 88.5mL DMEM from a 500mL DMEM bottle
and replacing it with 88.5mL FBS (Invitrogen, Carlsbad, CA). Under the
flow hood, the astrocytes were transferred from their vial to a new 15mL
tube. The vial was then rinsed with 1mL of the prepared medium,
dropwise, and this solution was subsequently added to the 15mL tube,
making a total volume of 2mL of cells. 8mL of complete medium were
then added to the tube to make a total of 10mL in the tube. This tube
was centrifuged for five minutes at 250 x g and then the supernatant was
decanted under the flow hood. 2mL medium were added to this 15mL
tube and the astrocytes were resuspended by pipetting up and down.
This solution was then pipetted onto a plate in a circular pattern, to
ensure distribution of the cells and spread them out across the plate.
Plated cells were observed under a microscope in order to ensure that
they were spread evenly and not crowding each other. The plate
containing the cells was then incubated at 37ºC, 5% CO2, 90% humidity.
Media was replaced approximately every 4 -5 days and a cell viability
(MTT) assay was done to test for cell stress. Four different populations of
astrocytes were compared: normal/untreated, treatment to reduce Cx43
expression (octanol) (Pekny and Nilsson, 2005), hydrogen peroxide
(H2O2) treatment to induce oxidative stress, and antioxidant treatment
(750 uM GCEE). The effects of Cx43 on neuronal damage was
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subsequently assessed through DCF and MTT assays (relative oxidative
stress levels and cell viability, respectively) of all four astrocytic
populations.
RESULTS
RNA extraction was performed on five separate occasions, as listed
in Table 2. Extractions were among hippocampal samples with different
treatments at different time points including sham, TBI + saline at 30
minutes, TBI + saline at 60 minutes, TBI + GCEE at 30 minutes, and TBI +
GCEE at 60 minutes. The samples are listed according to treatment
classification in Table 3. NanoDrop results indicated RNA samples
extracted were pure and of good quality, having a 260/280 abs of
approximately less than or equal to two, as depicted in Figure 1. All three
FlashGels™ run indicated that uncontaminated RNA was present in all
samples extracted, as shown in Figures 2, 3 and 4.
Extracted mRNA was successfully converted to cDNA through
reverse transcription and subsequently analyzed through qPCR. In order
to conserve use of resources, only twenty samples were run: six sham,
six TBI + GCEE at 30, and eight TBI + saline at 30. Samples used are listed
in Figures 13 and 14. Two qPCR plates were run and their corresponding
amplification plots are depicted in Figures 9 and 10. A schematic of the
two plates’ set-up and the samples run can be seen in Figures 13 and 14.
Fold-change calculations were done to determine the normalized gene
expression of Gja1 amongst the three different treatment populations.
Expression in the sham population was set to one, as a standard for
comparison. The fold change of the saline-treated samples was 1.412
compared to the sham control. The fold change of the GCEE-treated
samples was 0.903 compared to the sham control. A single-sided ANOVA
statistical analysis was performed with the ΔCT values of the qPCR for
each treatment, and is depicted in Figure 12. A single-sided ANOVA was
practical for statistical analysis of these results because it compares
variation with in situations where there are more than two treatment
types, or populations. A single-sided ANOVA compares the variation
between samples of one treatment type to the variation between the
differences observed in the different treatment types and indicates
whether or not there is a significant change observed between different
treatment types relative to the variation between samples in one
treatment type. Despite the trend observed, the results of the ANOVA
indicated that this trend was not statistically significant.
Cell culture work was delayed because the cells died during a 13day period of heavy snow that made the cells inaccessible and therefore
media could not be replaced. This experiment is a future direction and
will completed during the spring and summer 2015.
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CONCLUSIONS/DISCUSSION
Despite the lack of statistical significance from the results of the
qPCR research, a noteworthy trend does exist that should be investigated
further, and the implications of such a trend are discussed here.
Normalized fold-change of gene expression for GJA1 demonstrated an
increase from sham levels in the mTBI with administered saline 30
minutes post-injury. However, this increased level of GJA-1 expression
returned back to below sham levels for the mTBI with administered GCEE
30 minutes post-injury. If this trend is reflective of a statistically
significant phenomena, these results would indicate that the expression
of GJA-1, and consequentially the amount of Cx43 protein translated,
correlates with oxidative stress. The mTBI with saline model indicates
that there is more Cx43 protein translated when oxidative stress is
introduced. With the addition of the GCEE antioxidant, which substantially
relieves oxidative stress, there could be less of a need for Cx43, causing
GJA1 to be less expressed. These observations would likely support the
‘Good Samaritan’ view of Cx43’s role, as this oxidative-stress-dependent
presence would likely be compensatory. The increased expression of
GJA1 in the mTBI with saline treatment could support either the ‘Good
Samaritan’ or ‘Bystander Effect’ contentions, but the decrease in GJA1
expression observed after administering antioxidant more likely lends
itself to the ‘Good Samaritan’ hypothesis. A possible explanation for this
phenomenon is the synthesis of the most prominent natural antioxidant
employed by the body to combat oxidative stress: glutathione (GSH). GSH
is composed of three amino acids, glutamate, glycine and cysteine.
Because of the significantly lower concentration of cysteine in the brain
as compared to glycine and glutamate, cysteine is the limiting factor for
GSH synthesis (Drake, et al., 2002). GSH is available at greater levels in
astrocytes than in neurons, and is the most pronounced way that
astrocytes are able to protect neurons from oxidative stress. For cocultured systems containing both neurons and astrocytes, the neurons
were more susceptible to damage from oxidative stress if the astrocytes’
gap junctional communication was inhibited (Sáez, 2003). Astrocytic
protection of neurons is crippled when GSH levels are decreased in the
astrocytes, but when GSH is available astrocytes are able to protect
approximately twenty neurons per astrocyte against damage from
oxidative stress, particularly from the reactive oxidative species ,
hydrogen peroxide (Dringen, et al., 2000). GSH synthesis requires an
interplay between astrocytes and neurons. Cysteine availability limits GSH
production in neurons alone and determines their GSH levels. However,
when astrocytes are present, GSH levels increase in neurons, meaning
that astrocytes provide and essential cysteine- precursor that the neurons
are then able to use to fuel GSH production to combat oxidative stress.
This nature of this precursor has been experimentally identified as CysGly
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(Dringen et al., 2000). Because glutamine is released from astrocytes, and
CysGly is produced extracellularly through the action of an astrocytic
ectoenzyme, that reacts with GSH so that these components can be
uptaken by neurons and subsequently used to produce GSH within the
neurons, astrocytes furnish all three necessary ingredients for GSH
production to neurons (Dringen, et al., 2000). This interaction is depicted
in Figure 15. If the trend observed in the RNA work of this study is
statistically significant, it could be explained by this phenomenon, as the
Cx43 increase observed from TBI would aid diffusion of GSH, glutamine,
and ATP out of the astrocyte at a greater rate through Cx43
hemichannels, allowing for the raw materials for GSH synthesis to be
uptaken by the neurons. The decrease in Cx43 expression in the TBI with
GCEE treatment administered that may be reflective of a significant trend
would also make sense when considered in this context, because GCEE
would provide the raw materials needed for neuronal uptake to fuel GSH
production, bypassing the need for an increase in Cx43 hemichannels in
astrocytes since the diffusion of these reactants out of astrocytes would
be unnecessary since the reactants would already be provided by the
GCEE.
The metabolism of glutathione is depicted in Figure 17. GSH
synthesis requires ATP for two different steps, making ATP a limiting
factor as well depending on the antioxidant demands of the brain. In a
time of injury, when oxidative stress poses a serious threat to the health
of the brain, GSH production increases in order to help preserve the
brain’s tissues and functioning. Studies have demonstrated that a major
component of the release of ATP from astrocytes that occurs following
injury is through opening of Cx43 hemichannels because ATP can diffuse
through Cx43 hemichannels and Cx43-composed gap junctions (Huang,
et al., 2012). In this way, a plausible trend for GJA1 upregulation could be
reflective of the brain’s attempt at self-preservation by increasing the
amount of Cx43 so that Cx43 hemichannels or gap junctions can be
constructed to allow for the more rapid and widespread distribution of
ATP throughout astrocytes as well as increased ability for astrocytes to
provide the necessary reactants to neurons to facilitate neuronal
production of GSH and prevent neuronal damage from oxidative stress.
Cx43 hemichannels do not preferentially allow the passage of GSH, but
would help increase the rate of GSH synthesis in neurons by providing the
raw reactant needed. Additionally, the increased ATP release through
Cx43 gap junctions and hemichannels affects the formation of astrocytic
stress fibers, as well as the morphological changes that occur posttrauma, like cellular flattening (Lin, et al., 2003), which helps facilitate
reactive astrogliosis processes.
Aside from facilitating passage of signaling molecules, secondary
messengers, ATP, and ions, gap junctions also allow for the exchange of
small interfering RNA (siRNA) between cells (Dbouk, et al., 2009), which
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could allow it to regulate gene expression for certain proteins. Moreover,
Cx43 has been postulated as a regulator of gene expression through
recruitment of transcription factors (Giepmans,B. N G., 2004). Therefore,
the effects of Cx43 on gene expression of both protective and damaging
factors should be investigated further.
In the future, this research should be re-done with a greater sample
size per treatment type in order to determine whether or not the
observed trend is statistically significant. Moreover, it would be helpful to
investigate any possible relationship between p-Cx43 and treatment type.
Phosphorylation is a means of Cx43 regulation (Lampe and Lau, 2004)
and p-Cx43 is mostly concentrated in brain tissue six-hours post injury
(Ohsumi, et al., 2010), indicating that the phosphorylation state of Cx43
plays a role in post-traumatic processes, and it would be interesting to
investigate whether or not reducing Cx43 expression or administering an
antioxidant (i.e. GCEE) would have any effect on the ratio of
unphosphorylated-Cx43 and p-Cx43. Another future direction of this
research would be to assess the possible structural changes of the
astrocyte projections resulting from intermediate filament activity under
different treatment conditions, and observe any potential influence of
Cx43 on intermediate filament behavior or morphology to ultimately
assess if Cx43 plays a role in the morphological changes of astrocytes
during reactive astrogliosis that lead to glial scar formation and plaques.
Astrocytes upregulate their intermediate filament production following
trauma, facilitating the process of reactive astrogliosis and have been a
strong reason some researchers consider astrocytes to be predominantly
protective following injury (Pekny and Nilsson, 2005; Dbouk et al., 2009).
Moreover, mice with a predisposition to lower levels of Cx43 expression
were demonstrated to have less rapid upregulation of GFAP following
trauma, slowing the process of reactive astrogliosis (Ohsumi, et al. 2010).
Additionally, drebrin (developmentally-regulated brain protein) – a
protein that binds to actin, an important intermediate filament - is a
newly-recognized binding partner of Cx43’s carboxy-terminal tail and has
been implicated as a key player for maintenance of gap junctional
communication, responding to changes in cellular signaling, drebrindeficient astrocytes had lower levels of p-Cx43 and caused a decline in
the permeability of gap junctions (Butkevich, et al., 2004). Because Cx43
has direct interactions with multiple intermediate filaments, which is
related to the phosphorylation state of Cx43, it would be good to
research this relationship’s response to different treatment types
including one that induces oxidative stress (i.e. H2O2) and one that
reduces Cx43 expression (i.e. octanol).
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